NEA Management Company as of Dec. 31, 2022
Portfolio Holdings for NEA Management Company
NEA Management Company holds 57 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Coursera (COUR) | 10.5 | $188M | 16M | 11.83 | |
Arcellx Common Stock (ACLX) | 8.3 | $147M | 4.7M | 30.98 | |
Verona Pharma Sponsered Ads (VRNA) | 8.2 | $146M | 5.6M | 26.13 | |
Rhythm Pharmaceuticals (RYTM) | 8.0 | $143M | 4.9M | 29.12 | |
Bright Health Group | 8.0 | $142M | 218M | 0.65 | |
Cloudflare Cl A Com (NET) | 4.8 | $85M | 1.9M | 45.21 | |
Mirum Pharmaceuticals (MIRM) | 4.6 | $82M | 4.2M | 19.50 | |
ZeroFox Holdings | 4.6 | $81M | 18M | 4.48 | |
Oyster Point Pharma | 3.7 | $66M | 5.9M | 11.17 | |
Crispr Therapeutics Namen Akt (CRSP) | 3.6 | $65M | 1.6M | 40.65 | |
Monte Rosa Therapeutics (GLUE) | 3.3 | $59M | 7.7M | 7.61 | |
Allakos (ALLK) | 2.9 | $52M | 6.1M | 8.42 | |
Ionq Inc Pipe (IONQ) | 2.8 | $50M | 15M | 3.45 | |
CVRX (CVRX) | 2.4 | $44M | 2.4M | 18.35 | |
Geron Corporation (GERN) | 2.2 | $40M | 16M | 2.42 | |
Savara (SVRA) | 2.1 | $37M | 24M | 1.55 | |
Glycomimetics (GLYC) | 1.5 | $27M | 9.0M | 3.03 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.4 | $25M | 17M | 1.46 | |
Nextnav Common Stock (NN) | 1.3 | $24M | 8.2M | 2.93 | |
Berkshire Grey Com Cl A | 1.3 | $23M | 38M | 0.60 | |
Cti Biopharma | 1.2 | $22M | 3.7M | 6.01 | |
Trevi Therapeutics (TRVI) | 1.2 | $22M | 11M | 1.93 | |
Nkarta (NKTX) | 1.2 | $21M | 3.6M | 5.99 | |
Desktop Metal Com Cl A | 1.1 | $20M | 14M | 1.36 | |
Celcuity (CELC) | 1.0 | $18M | 1.3M | 14.01 | |
Aurinia Pharmaceuticals (AUPH) | 1.0 | $17M | 4.0M | 4.32 | |
X4 Pharmaceuticals (XFOR) | 0.7 | $12M | 12M | 0.99 | |
Reneo Pharmaceuticals (RPHM) | 0.6 | $11M | 4.8M | 2.33 | |
Buzzfeed Class A Com | 0.6 | $11M | 15M | 0.69 | |
Fiscalnote Holdings Com Cl A (NOTE) | 0.5 | $9.7M | 1.7M | 5.70 | |
Tuya Sponsered Ads (TUYA) | 0.5 | $9.4M | 4.9M | 1.91 | |
Champions Oncology Com New (CSBR) | 0.4 | $7.7M | 1.7M | 4.51 | |
Gossamer Bio (GOSS) | 0.4 | $7.5M | 3.5M | 2.17 | |
Inventiva Sa Ads (IVA) | 0.4 | $7.0M | 1.5M | 4.79 | |
Bill Com Holdings Ord (BILL) | 0.4 | $6.8M | 66k | 103.51 | |
Black Diamond Therapeutics (BDTX) | 0.3 | $6.2M | 3.4M | 1.80 | |
Affimed Therapeutics B V | 0.3 | $5.5M | 4.4M | 1.24 | |
Senti Biosciences Ord (SNTI) | 0.3 | $5.3M | 4.4M | 1.21 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.3 | $4.6M | 2.4M | 1.91 | |
Acrivon Therapeutics Common Stock (ACRV) | 0.2 | $4.4M | 482k | 9.22 | |
Xeris Pharmaceuticals (XERS) | 0.2 | $4.3M | 3.2M | 1.33 | |
Synlogic | 0.2 | $3.2M | 4.2M | 0.76 | |
Marker Therapeutics Ord | 0.2 | $2.8M | 11M | 0.27 | |
Satsuma Pharmaceuticals Ord | 0.2 | $2.7M | 3.0M | 0.90 | |
Eargo | 0.1 | $2.6M | 4.5M | 0.57 | |
Inozyme Pharma (INZY) | 0.1 | $2.6M | 2.4M | 1.05 | |
Minerva Surgical | 0.1 | $2.2M | 10M | 0.22 | |
Mei Pharma Com New | 0.1 | $2.1M | 8.5M | 0.24 | |
Regulus Therapeutics | 0.1 | $2.0M | 1.4M | 1.37 | |
Airspan Networks Holdings (MIMOQ) | 0.1 | $1.8M | 1.4M | 1.31 | |
Wheels Up Experience Com Cl A | 0.1 | $1.1M | 1.1M | 1.03 | |
Obseva Sa | 0.0 | $665k | 4.6M | 0.14 | |
Akari Therapeutics Sponsored Adr | 0.0 | $213k | 452k | 0.47 | |
Addex Therapeutics Sponsored Ads | 0.0 | $113k | 1.1M | 0.10 | |
Airspan Networks Holdings *w Exp 08/13/2023 | 0.0 | $209.784000 | 70k | 0.00 | |
Airspan Networks Holdings *w Exp 08/13/2023 | 0.0 | $111.884800 | 70k | 0.00 | |
Airspan Networks Holdings *w Exp 08/13/2023 | 0.0 | $62.935200 | 70k | 0.00 |